Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...

Abstract: A successive-approximation ADC with non-binary code achieves 55dB SNR at sampling frequencies up to 20MHz. The converter, with on-chip driver for analog input and reference input, measures 0 ...

EnterpriseDB (EDB), the leading sovereign AI and data company, today announced new investments in petabyte-scale analytics, expanding EDB Postgres AI (EDB PG AI) for WarehousePG with real-time ...